Steven Zweig

Suggest Changes
Learn More
UNLABELLED The hepatotoxic potential of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in patients with underlying chronic liver disease remains controversial. We performed a multicenter,(More)